Arcadia Biosciences Revenue, Profits - RKDA Quarterly Income Statement

Add to My Stocks
$6.33 $0.75 (13.44%) RKDA stock closing price Aug 17, 2018 (Closing)

Fundamental analysis of RKDA stock involves analyzing its financial statements, apart from checking the Arcadia Biosciences stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for RKDA which shows a YOY revenue decline of 0 is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Revenue for year 2018 Q2 is $- and has decreased from $- quarter on quarter as is evident when you compare the latest figures in the latest Arcadia Biosciences profit and loss statement with those of the prior corresponding period. Also see Arcadia Biosciences assets and Arcadia Biosciences free cash flow for a complete valuation of RKDA stock.

View and download details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Arcadia Biosciences Revenues or Net Sales
Cost Of Goods Sold (COGS)----------
Arcadia Biosciences Gross Profit
Research & Development Expense1.79M1.39M2.18M1.74M1.66M1.82M2M2.25M2.21M2.2M
Selling General & Admin Expense2.95M2.62M2.25M2.41M2.94M3.05M3.39M2.68M2.75M3.43M
Income Before Depreciation Depletion Amortization-4.58M-3.83M-3.01M-3.61M-3.73M-3.96M-5.49M-3.92M-4.28M-4.93M
Depreciation Depletion Amortization----------
Non Operating Income-2.08M-6.76M--0.85M------
Interest Expense----------
Arcadia Biosciences Pretax Income
Provision for Income Taxes---0.01M-------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-6.67M-10.62M-2.96M-4.53M-4.01M-4.22M-5.71M-4.18M-4.55M-5.19M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS3.31M2.19M2.13M2.13M2.13M2.22M2.2M2.22M2.22M2.21M
Average Shares used to compute Basic EPS3.31M2.19M2.13M2.13M2.13M2.22M2.2M2.22M2.22M2.21M
Income Before Nonrecurring Items-6.67M-10.62M-2.96M-4.53M-4.01M-4.22M-5.71M-4.18M-4.55M-5.19M
Income from Nonrecurring Items----------
Arcadia Biosciences Earnings Per Share Basic Net
Arcadia Biosciences Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-2.02-4.86-1.39-2.20-1.80-2.00-2.60-1.80-2.00-2.40
Preferred Dividends Acc Pd----------
Dividends Common0.000.000.00-------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Arcadia Biosciences stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this quarter of 2018 Q2. Our Arcadia Biosciences revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: Most businesses like Arcadia Biosciences try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The RKDA financials along with Arcadia Biosciences historical stock prices provide a lot of details about the firm.

Arcadia Biosciences Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield